Danaher Co. to Issue Quarterly Dividend of $0.17 (NYSE:DHR)

Danaher Co. (NYSE:DHR) declared a quarterly dividend on Tuesday, September 10th, RTT News reports. Investors of record on Friday, September 27th will be paid a dividend of 0.17 per share by the conglomerate on Friday, October 25th. This represents a $0.68 dividend on an annualized basis and a yield of 0.49%.

Danaher has increased its dividend payment by an average of 7.1% annually over the last three years. Danaher has a dividend payout ratio of 15.1% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Danaher to earn $5.49 per share next year, which means the company should continue to be able to cover its $0.68 annual dividend with an expected future payout ratio of 12.4%.

NYSE:DHR traded up $3.12 during trading hours on Wednesday, hitting $139.71. The stock had a trading volume of 120,869 shares, compared to its average volume of 1,809,357. The business’s 50 day moving average is $140.24 and its 200-day moving average is $134.97. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.91 and a current ratio of 2.32. The company has a market cap of $99.97 billion, a price-to-earnings ratio of 30.90, a P/E/G ratio of 2.52 and a beta of 0.94. Danaher has a one year low of $94.59 and a one year high of $145.50.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Thursday, July 18th. The conglomerate reported $1.19 earnings per share for the quarter, topping analysts’ consensus estimates of $1.15 by $0.04. The company had revenue of $5.16 billion for the quarter, compared to analysts’ expectations of $5.09 billion. Danaher had a net margin of 12.22% and a return on equity of 11.53%. The business’s quarterly revenue was up 3.5% compared to the same quarter last year. During the same period last year, the firm posted $1.15 earnings per share. On average, sell-side analysts anticipate that Danaher will post 4.79 EPS for the current fiscal year.

In other Danaher news, Chairman Mitchell P. Rales purchased 2,500 shares of the stock in a transaction on Friday, August 23rd. The shares were purchased at an average cost of $139.52 per share, for a total transaction of $348,800.00. Following the purchase, the chairman now owns 3,030,453 shares of the company’s stock, valued at $422,808,802.56. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Angela S. Lalor sold 20,000 shares of the business’s stock in a transaction dated Tuesday, July 23rd. The stock was sold at an average price of $142.30, for a total transaction of $2,846,000.00. Following the sale, the senior vice president now directly owns 58,515 shares in the company, valued at $8,326,684.50. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 177,202 shares of company stock valued at $25,175,829. Insiders own 11.40% of the company’s stock.

DHR has been the subject of several recent analyst reports. Argus increased their price target on Danaher to $165.00 and gave the stock a “buy” rating in a report on Tuesday, July 23rd. Royal Bank of Canada set a $134.00 price objective on Danaher and gave the company a “hold” rating in a report on Friday, July 19th. Wolfe Research assumed coverage on Danaher in a research report on Thursday, May 30th. They issued an “outperform” rating for the company. Robert W. Baird increased their target price on Danaher from $131.00 to $148.00 and gave the stock an “outperform” rating in a research note on Friday, July 19th. Finally, Piper Jaffray Companies raised their target price on shares of Danaher from $148.00 to $153.00 and gave the stock a “neutral” rating in a report on Thursday, July 18th. Three research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Danaher presently has a consensus rating of “Buy” and an average price target of $143.54.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Further Reading: How Does the Quiet Period Work?

Dividend History for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.